Islet alpha cell number is maintained in microencapsulated islet transplantation

Biochemical and Biophysical Research Communications

Volumn 377, Issue 2, 2008, Pages 729-733

  Bohman, Sara ^a   King, Aileen J F ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alginate; Alpha cells; Glucagon; Islet transplantation; Microencapsulation

Indexed keywords

GLUCAGON; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; DNA CONTENT; HORMONE RESPONSE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; CAPSULES; CELL COUNT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DNA; GLUCAGON; GLUCAGON-SECRETING CELLS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 55549137691     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.059     Document Type: Article

References (28)

1. Ryan E.A., Paty B.W., Senior P.A., Bigam D., Alfadhli E., Kneteman N.M., Lakey J.R., and Shapiro A.M. Five-year follow-up after clinical islet transplantation. Diabetes 54 (2005) 2060-2069
2. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., Kneteman N.M., and Rajotte R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343 (2000) 230-238
3. Kendall D.M., Teuscher A.U., and Robertson R.P. Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes 46 (1997) 23-27
4. Paty B.W., Ryan E.A., Shapiro A.M., Lakey J.R., and Robertson R.P. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51 (2002) 3428-3434
5. Gunther L., Liu X., Neeff H., Drognitz O., and Hopt U.T. Glucagon expression shift in a syngeneic single-donor intrahepatic rat islet transplantation model. Transplant. Proc. 37 (2005) 3487-3489
6. Gustavson S.M., Rajotte R.V., Hunkeler D., Lakey J.R., Edgerton D.S., Neal D.W., Snead W.L., Penaloza A.R., and Cherrington A.D. Islet auto-transplantation into an omental or splenic site results in a normal beta cell but abnormal alpha cell response to mild non-insulin-induced hypoglycemia. Am. J. Transplant. 5 (2005) 2368-2377
7. Lau J., Jansson L., and Carlsson P.O. Islets transplanted intraportally into the liver are stimulated to insulin and glucagon release exclusively through the hepatic artery. Am. J. Transplant. 6 (2006) 967-975
8. King A.J., Fernandes J.R., Hollister-Lock J., Nienaber C.E., Bonner-Weir S., and Weir G.C. Normal relationship of beta- and non-beta-cells not needed for successful islet transplantation. Diabetes 56 (2007) 2312-2318
9. Morini S., Brown M.L., Cicalese L., Elias G., Carotti S., Gaudio E., and Rastellini C. Revascularization and remodelling of pancreatic islets grafted under the kidney capsule. J. Anat. 210 (2007) 565-577
10. Zhou H., Zhang T., Bogdani M., Oseid E., Parazzoli S., Vantyghem M.C., Harmon J., Slucca M., and Robertson R.P. Intrahepatic glucose flux as a mechanism for defective intrahepatic islet alpha-cell response to hypoglycemia. Diabetes 57 (2008) 1567-1574
11. Davalli A.M., Scaglia L., Zangen D.H., Hollister J., Bonner-Weir S., and Weir G.C. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45 (1996) 1161-1167
12. Davalli A.M., Ogawa Y., Scaglia L., Wu Y.J., Hollister J., Bonner-Weir S., and Weir G.C. Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44 (1995) 104-111
13. Eich T., Eriksson O., and Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N. Engl. J. Med. 356 (2007) 2754-2755
14. Biarnes M., Montolio M., Nacher V., Raurell M., Soler J., and Montanya E. Beta-cell death and mass in syngenetically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51 (2002) 66-72
15. Chang T.M. Semipermeable microcapsules. Science 146 (1964) 524-525
16. Lim F., and Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210 (1980) 908-910
17. Sun A.M., Goosen M.F., and O'Shea G. Microencapsulated cells as hormone delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 4 (1987) 1-12
18. Duvivier-Kali V.F., Omer A., Parent R.J., O'Neil J.J., and Weir G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50 (2001) 1698-1705
19. King A., Sandler S., Andersson A., Hellerstrom C., Kulseng B., and Skjak-Braek G. Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets microencapsulated by means of a high-voltage electrostatic field. Diabetes Care 22 Suppl. 2 (1999) B121-B126
20. Omer A., Duvivier-Kali V.F., Aschenbach W., Tchipashvili V., Goodyear L.J., and Weir G.C. Exercise induces hypoglycemia in rats with islet transplantation. Diabetes 53 (2004) 360-365
21. Schuit F., De V.A., Farfari S., Moens K., Pipeleers D., Brun T., and Prentki M. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J. Biol. Chem. 272 (1997) 18572-18579
22. R.B. Elliott, L. Escobar, P.L.J. Tan, M. Muzina, S. Zwain, C. Buchanan, Live encapsulated porcine islets from a type 1 diabetic 9.5 yr after xenotransplantation, in: Anonymous, 2007, pp. 157-161.
23. Yoon K.H., Ko S.H., Cho J.H., Lee J.M., Ahn Y.B., Song K.H., Yoo S.J., Kang M.I., Cha B.Y., Lee K.W., Son H.Y., Kang S.K., Kim H.S., Lee I.K., and Bonner-Weir S. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J. Clin. Endocrinol. Metab. 88 (2003) 2300-2308
24. Collins S.C., Salehi A., Eliasson L., Olofsson C.S., and Rorsman P. Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon. Diabetologia 51 (2008) 1689-1693
25. Li Z., Karlsson F.A., and Sandler S. Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. J. Endocrinol. 165 (2000) 93-99
26. Unger R.H., Guilar-Parada E., Muller W.A., and Eisentraut A.M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J. Clin. Invest. 49 (1970) 837-848
27. Maruyama H., Hisatomi A., Orci L., Grodsky G.M., and Unger R.H. Insulin within islets is a physiologic glucagon release inhibitor. J. Clin. Invest. 74 (1984) 2296-2299
28. Zhou H., Zhang T., Harmon J.S., Bryan J., and Robertson R.P. Zinc not insulin regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes 56 (2007) 1107-1112